Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-15 | ANI PHARMACEUTICALS INC | Rowland Thomas An...
(SVP, HEAD - ESTABLISHED BRANDS) |
F | Common Stock | D | 867 | $56.58 - $56.58 | $49,054 |
| 2024-10-14 | ANI PHARMACEUTICALS INC | Cook Meredith
(SR. VP, GENERAL COUNSEL & SEC.) |
S | Common Stock | D | 250 | $57.19 - $57.19 | $14,297 |
| 2024-09-13 | ANI PHARMACEUTICALS INC | Cook Meredith
(SR. VP, GENERAL COUNSEL & SEC.) |
S | Common Stock | D | 250 | $56.82 - $56.82 | $14,205 |
| 2024-09-08 | ANI PHARMACEUTICALS INC | Lalwani Nikhil
(PRESIDENT & CEO) |
F | Common Stock | D | 3646 | $60.51 - $60.51 | $220,619 |
| 2024-08-13 | ANI PHARMACEUTICALS INC | Cook Meredith
(SR. VP, GENERAL COUNSEL & SEC.) |
S | Common Stock | D | 250 | $59.62 - $59.62 | $14,905 |
| 2024-07-18 | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy
(HEAD OF R&D, COO-NOVITIUM OPS) |
S | Common Stock | D | 2743 | $62.00 - $62.00 | $170,066 |
| 2024-07-18 | ANI PHARMACEUTICALS INC | Cook Meredith
(SR. VP, GENERAL COUNSEL & SEC.) |
F | Common Stock | D | 1743 | $61.35 - $61.35 | $106,933 |
| 2024-07-15 | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy
(HEAD OF R&D, COO-NOVITIUM OPS) |
S | Common Stock | D | 47257 | $63.16 - $64.27 | $3,011,592 |
| 2024-07-12 | ANI PHARMACEUTICALS INC | Cook Meredith
(SR. VP, GENERAL COUNSEL & SEC.) |
S | Common Stock | D | 250 | $64.91 - $64.91 | $16,227 |
| 2024-07-01 | ANI PHARMACEUTICALS INC | Gassert Chad
(SVP - CORP. DEV. & STRATEGY) |
S | Common Stock | D | 20000 | $63.44 - $63.44 | $1,268,800 |
| 2024-06-17 | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy
(HEAD OF R&D, COO-NOVITIUM OPS) |
S | Common Stock | D | 30000 | $59.86 - $61.41 | $1,817,661 |
| 2024-06-13 | ANI PHARMACEUTICALS INC | Cook Meredith
(SR. VP, GENERAL COUNSEL & SEC.) |
S | Common Stock | D | 250 | $63.80 - $63.80 | $15,950 |
| 2024-06-05 | ANI PHARMACEUTICALS INC | Gutwerg Ori
(SVP, GENERICS) |
S | Common Stock | D | 2985 | $67.00 - $67.00 | $199,995 |
| 2024-06-04 | ANI PHARMACEUTICALS INC | CAREY STEPHEN P.
(SVP & CFO) |
S | Common Stock | D | 5000 | $63.58 - $63.58 | $317,900 |
| 2024-06-03 | ANI PHARMACEUTICALS INC | Gassert Chad
(SVP - CORP. DEV. & STRATEGY) |
S | Common Stock | D | 20000 | $64.41 - $64.41 | $1,288,200 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |